SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-057472
Filing Date
2024-05-10
Accepted
2024-05-10 08:31:32
Documents
69
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q itos-20240331.htm   iXBRL 10-Q 1937901
2 EX-31.1 itos-ex31_1.htm EX-31.1 15340
3 EX-31.2 itos-ex31_2.htm EX-31.2 15344
4 EX-32.1 itos-ex32_1.htm EX-32.1 15700
  Complete submission text file 0000950170-24-057472.txt   8110606

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT itos-20240331.xsd EX-101.SCH 1226383
73 EXTRACTED XBRL INSTANCE DOCUMENT itos-20240331_htm.xml XML 1323275
Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583
iTeos Therapeutics, Inc. (Filer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39401 | Film No.: 24932979
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)